Janus Henderson Group PLC Blueprint Medicines Corp Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 28,749 shares of BPMC stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,749
Previous 28,749
-0.0%
Holding current value
$2.72 Million
Previous $3.1 Million
14.2%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$628 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$509 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$375 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$261 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.64B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...